Slide 1
A growing solid tumour needs oxygen and nutrients
A growing solid tumour needs access to oxygen and nutrients. Its relationship with blood vessels helps shape what further growth is possible.
More to Read
Cancer cells exist among non-cancerous cells, connective tissue and vessels. This surrounding microenvironment can assist or constrain growth, making the disease more than the behavior of isolated abnormal cells.
Slide 2
Angiogenesis forms new vessels in response to signals
Angiogenesis means the formation of new blood vessels. Tumours can release signals that encourage nearby vascular cells to grow.
More to Read
Vascular endothelial growth factor, often shortened to VEGF, is one important signal in this process. Its effects depend on receptors and interactions with other signals rather than a single command acting alone.
Slide 3
Many abnormal vessels can still supply a tumour unevenly
Tumour-associated vessels can be structurally and functionally abnormal. Having many vessels does not guarantee even delivery throughout a mass.
More to Read
Uneven blood flow and permeability can create different local conditions within the same tumour. Researchers study these differences because they can influence immune activity and treatment response.
Slide 4
Some medicines target vessel-growth signals
Some cancer medicines interfere with signals involved in vessel growth. This approach targets a support process needed by certain tumours.
More to Read
Normal tissues also use vascular growth in processes such as healing. A mechanism shared with healthy tissue helps explain why targeting it can have unwanted effects as well as potential benefits.
Slide 5
The mechanism alone cannot choose a treatment
Knowing a tumour uses blood vessels does not determine its treatment. Clinical usefulness depends on the cancer, the medicine and evidence from studies.
More to Read
Angiogenesis inhibitors can be combined with other treatments in particular settings. The example shows how a biological idea must be tested in a specific clinical context before becoming a useful intervention.
Sources
- Angiogenesis Inhibitors
National Cancer Institute
- Tumor Biology and Microenvironment Research
National Cancer Institute